83 FR 58779 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 225 (November 21, 2018)

Page Range		58779-58779
FR Document		2018-25356

Federal Register, Volume 83 Issue 225 (Wednesday, November 21, 2018)

[Federal Register Volume 83, Number 225 (Wednesday, November 21, 2018)]
[Notices]
[Page 58779]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-25356]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Chronic Neurodegenerative Diseases.
    Date: December 11, 2018.
    Time: 1:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Seetha Bhagavan, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 
20892, (301) 237-9838, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: November 15, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-25356 Filed 11-20-18; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 225 / Wednesday, November 21, 2018 / Notices 58779

Related to Neurological Disorders; 93.854, DEPARTMENT OF HEALTH AND SUMMARY: This notice is to inform the
Biological Basis Research in the HUMAN SERVICES public that the Substance Abuse and
Neurosciences, National Institutes of Health, Mental Health Services Administration
HHS) National Institutes of Health (SAMHSA) intends to award $500,000
Dated: November 14, 2018. (total costs) for up to five years to
Center for Scientific Review; Notice of CADCA for the National Anti-Drug
Sylvia L. Neal,
Closed Meeting Coalitions Training and Workforce
Program Analyst, Office of Federal Advisory
Committee Policy. Pursuant to section 10(d) of the Development Grant. Under this
Federal Advisory Committee Act, as initiative, CADCA will provide training
[FR Doc. 2018–25355 Filed 11–20–18; 8:45 am]
amended, notice is hereby given of the to state and community prevention
BILLING CODE 4140–01–P
following meeting. leaders, including members of anti-drug
The meeting will be closed to the community coalitions from around the
public in accordance with the country who are committed to
DEPARTMENT OF HEALTH AND
provisions set forth in sections addressing the evolving needs of the
HUMAN SERVICES behavioral health field, and promote
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
National Institutes of Health as amended. The grant applications and workforce development. Training and
the discussions could disclose workforce development activities
National Heart, Lung, and Blood confidential trade secrets or commercial supported through this grant include
Institute; Notice of Meetings property such as patentable material, SAMHSA’s Prevention Day, the CADCA
and personal information concerning National Leadership Forum, and
Pursuant to section 10(d) of the individuals associated with the grant CADCA’s Mid-Year Training Institute.
Federal Advisory Committee Act, as applications, the disclosure of which These activities aim to disseminate
amended, notice is hereby given of the would constitute a clearly unwarranted knowledge and transfer state-of-the-art
following meetings. invasion of personal privacy. information, assisting state and
community leaders in developing and
The meetings will be closed to the Name of Committee: Center for Scientific implementing evidence-based programs,
public in accordance with the Review Special Emphasis Panel; Member
Conflict: Chronic Neurodegenerative practices, and policies aligned with the
provisions set forth in sections 21st Century Cures Act, the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Diseases.
Date: December 11, 2018. Comprehensive Addition and Recovery
as amended. The grant applications and Time: 1:00 p.m. to 3:30 p.m. Act, the President’s Commission on
the discussions could disclose Agenda: To review and evaluate grant combating drug addiction and the
confidential trade secrets or commercial applications. opioid crisis, and other national
property such as patentable material, Place: National Institutes of Health, 6701 substance abuse prevention goals,
and personal information concerning Rockledge Drive, Bethesda, MD 20892 outcomes, and efforts, including
individuals associated with the grant (Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D.,
underage drinking prevention. This is
applications, the disclosure of which not a formal request for applications.
would constitute a clearly unwarranted Scientific Review Officer, Center for
Scientific Review, National Institutes of Assistance will be provided only to
invasion of personal privacy. Health, 6701 Rockledge Drive, Room 5194, CADCA based on the receipt of a
Name of Committee: National Heart, Lung, MSC 7846, Bethesda, MD 20892, (301) 237– satisfactory application that is approved
and Blood Institute Special Emphasis Panel; 9838, bhagavas@csr.nih.gov. by an independent review group.
Conference Grants in Support of Heart, Lung, (Catalogue of Federal Domestic Assistance Funding Opportunity Title: SP–19–
and Blood Research. Program Nos. 93.306, Comparative Medicine; 002.
Date: December 11–12, 2018. 93.333, Clinical Research, 93.306, 93.333, Catalog of Federal Domestic
Time: 8:00 a.m. to 5:30 p.m. 93.337, 93.393–93.396, 93.837–93.844, Assistance (CFDA) Number: 93.243.
Agenda: To review and evaluate grant 93.846–93.878, 93.892, 93.893, National Authority: Section 516 of the Public
applications. Institutes of Health, HHS) Health Services Act, as amended.
Place: National Institutes of Health, 6701 Dated: November 15, 2018.
Rockledge Drive, Room 7296, Bethesda, MD Justification
Ronald J. Livingston, Jr.,
20892 (Virtual Meeting). Eligibility for this award is limited to
Program Analyst, Office of Federal Advisory
Contact Person: Stephanie J. Webb, Ph.D., CADCA. The purpose of this grant to
Committee Policy.
Scientific Review Officer, Office of Scientific provide training and workforce
[FR Doc. 2018–25356 Filed 11–20–18; 8:45 am]
Review, National Heart, Lung, and Blood development for thousands of members
Institute, National Institutes of Health, 6701 BILLING CODE 4140–01–P
of community coalitions dedicated to
Rockledge Drive, Room 7196, Bethesda, MD
preventing substance abuse through a
20892, 301–287–7332, stephanie.webb@
DEPARTMENT OF HEALTH AND national leadership workforce
nih.gov.
HUMAN SERVICES development and training event.
(Catalogue of Federal Domestic Assistance CADCA is the only national
Program Nos. 93.233, National Center for
Substance Abuse and Mental Health organization that has special expertise
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Services Administration and unique broad, national-level
Diseases Research; 93.839, Blood Diseases experience in working with community
Fiscal Year (FY) 2019 Funding anti-drug coalitions. For more than 22
and Resources Research, National Institutes
Opportunity years, coalitions and coalition
khammond on DSK30JT082PROD with NOTICES

of Health, HHS)
AGENCY: Substance Abuse and Mental leadership have turned to CADCA to
Dated: November 15, 2018.
Health Services Administration, HHS. obtain the assistance they need to
Ronald J. Livingston, Jr., implement, operate, and sustain
ACTION: Notice of intent to award a
Program Analyst, Office of Federal Advisory effective local community anti-drug
Committee Policy. single source grant to the Community
strategies. CADCA will take advantage
Anti-Drug Coalitions of America
[FR Doc. 2018–25353 Filed 11–20–18; 8:45 am] of the resources of multiple agencies
(CADCA).
BILLING CODE 4140–01–P located throughout the federal, state and

VerDate Sep<11>2014 16:08 Nov 20, 2018 Jkt 247001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 E:\FR\FM\21NON1.SGM 21NON1

Document Created: 2018-11-21 03:11:23
Document Modified: 2018-11-21 03:11:23

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		December 11, 2018.
FR Citation		83 FR 58779

83 FR 58779 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 225 (November 21, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health